University of Michigan spinoff company Courage Therapeutics is based in Massachusetts and develops medicines targeting ...

acquiring Carmot Therapeutics and partnering with Zealand, and AstraZeneca, partnering with Eccogene, have done. We should also note that while Novo's deal with Septerna involves a $195m upfront ...

Analysts' ratings for Septerna (NASDAQ:SEPN) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below provides a snapshot of their recent ratings, showcasing ...

Septerna's partnership with Novo Nordisk validates its GPCR drug discovery platform and injects $195 million in upfront cash, with potential for more than $2 billion in milestone payments. The ...

Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal ...

Gifting allows recipients to access the article for free. University of Michigan spinout company Courage Therapeutics has raised $7.8 million as part of its seed round, the company announced Friday.

Novo Nordisk is teaming up with U.S. biotech Septerna to create a new obesity pill Septerna could receive up to $2.2 billion in funding The goal is to develop pills that target special proteins in ...

May 16 (UPI) --Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases. The deal ...

On Friday, Cantor Fitzgerald’s analysts showed confidence in Septerna Inc (NASDAQ: SEPN), as they raised the company’s price target from $20.00 to $25.00 while keeping an Overweight rating on the ...

Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to ...